Here are the DEF 14A proxy statements from Universal Technical Institute, Inc. (UTI) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow UTI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full UTI filings page.
Universal Technical Institute calls a virtual 2026 annual stockholder meeting on March 12, 2026, asking investors to elect three Class I directors, ratify Deloitte & Touche as auditor for fiscal 2026, and approve an advisory Say on Pay vote for named executive officer compensation.
The proxy highlights a 2025 revenue increase to $835.6 million, up 14.0% from the prior year, with operating income of $83.5 million, up 41.7%, and net income of $63.0 million, up 50%. Growth came from higher full-time student counts and program expansion across the UTI and Concorde segments.
The board has ten members, a majority independent, with specialized committees for audit, compensation, governance, public policy, and strategic opportunities. Director pay combines cash retainers with equity awards, while executive pay blends salary, annual incentives and long-term equity; 2025 bonuses paid at 121% of target and long-term grants were split 50% performance stock units and 50% restricted stock units. The company emphasizes stock ownership guidelines, a clawback policy, and prohibitions on hedging to align leadership with stockholders.